Blood-brain barrier disruption in atrial fibrillation: a potential contributor to the increased risk of dementia and worsening of stroke outcomes?

被引:18
作者
Aryal, Ritambhara [1 ,2 ]
Patabendige, Adjanie [1 ,2 ,3 ]
机构
[1] Univ Newcastle, Sch Biomed Sci & Pharm, Brain Barriers Grp, Callaghan, NSW 2308, Australia
[2] Hunter Med Res Inst, Brain & Mental Hlth Res Programme, Newcastle, NSW, Australia
[3] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England
关键词
blood-brain barrier; atrial fibrillation; dementia; cognitive impairment; stroke; cerebral blood flow; DYNAMIC CEREBRAL AUTOREGULATION; ASTROCYTE-MEDIATED CONTROL; TRANSIENT ISCHEMIC ATTACK; VON-WILLEBRAND-FACTOR; CELL-CULTURE MODELS; IN-VITRO MODELS; LONG-TERM RISK; OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE;
D O I
10.1098/rsob.200396
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Atrial fibrillation (AF) has become one of the most significant health problems worldwide, warranting urgent answers to currently pending questions on the effects of AF on brain function. Recent evidence has emerged to show an association between AF and an increased risk of developing dementia and worsening of stroke outcomes. A healthy brain is protected by the blood-brain barrier (BBB), which is formed by the endothelial cells that line cerebral capillaries. These endothelial cells are continuously exposed to shear stress (the frictional force generated by blood flow), which affects endothelial cell structure and function. Flow disturbances as experienced during AF can disrupt the BBB and leave the brain vulnerable to damage. Investigating the plausible mechanisms in detail, linking AF to cerebrovascular damage is difficult in humans, leading to paucity of available clinical data. Here, we discuss the available evidence for BBB disruption during AF due to altered cerebral blood flow, and how this may contribute to an increased risk of dementia and worsening of stroke outcomes.
引用
收藏
页数:15
相关论文
共 249 条
[51]   Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases [J].
Cekanaviciute, Egle ;
Buckwalter, Marion S. .
NEUROTHERAPEUTICS, 2016, 13 (04) :685-701
[52]   PAROXYSMAL ATRIAL-FIBRILLATION ASSOCIATED WITH AN ATTACK OF MULTIPLE-SCLEROSIS [J].
CHAGNAC, Y ;
MARTINOVITS, G ;
TADMOR, R ;
GOLDHAMMER, Y .
POSTGRADUATE MEDICAL JOURNAL, 1986, 62 (727) :385-387
[53]   Stroke Propensity Is Increased under Atrial Fibrillation Hemodynamics: A Simulation Study [J].
Choi, Hyo Won ;
Navia, Jose A. ;
Kassab, Ghassan S. .
PLOS ONE, 2013, 8 (09)
[54]   Prediction of vascular dementia and Alzheimer's disease in patients with atrial fibrillation or atrial flutter using CHADS2 score [J].
Chou, Ruey-Hsing ;
Chiu, Chun-Chih ;
Huang, Chin-Chou ;
Chan, Wan-Leong ;
Huang, Po-Hsun ;
Chen, Yu-Chun ;
Chen, Tzeng-Ji ;
Chung, Chia-Min ;
Lin, Shing-Jong ;
Chen, Jaw-Wen ;
Leu, Hsin-Bang .
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2016, 79 (09) :470-476
[55]  
Chughtai M, 2015, STROKE, V46
[56]  
Cipolla M.J., 2009, Control of Cerebral Blood Flow
[57]   Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation [J].
Conway, DSG ;
Pearce, LA ;
Chin, BSP ;
Hart, RG ;
Lip, GYH .
CIRCULATION, 2003, 107 (25) :3141-3145
[58]   EFFECT OF CARDIAC ARRHYTHMIAS ON THE CEREBRAL CIRCULATION [J].
CORDAY, E ;
IRVING, DW .
AMERICAN JOURNAL OF CARDIOLOGY, 1960, 6 (04) :803-808
[59]   Atrial fibrillation from the pathologist's perspective [J].
Corradi, Domenico .
CARDIOVASCULAR PATHOLOGY, 2014, 23 (02) :71-84
[60]   Progressive multiple sclerosis: from pathogenic mechanisms to treatment [J].
Correale, Jorge ;
Gaitan, Maria I. ;
Ysrraelit, Maria C. ;
Fiol, Marcela P. .
BRAIN, 2017, 140 :527-546